Lv61
2490 积分 2023-06-24 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
6小时前
已完结
Response and Resistance to RAS Inhibition in Cancer
9天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
25天前
已完结
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
25天前
已完结
Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal Cancer
1个月前
已完结
Targeting KRAS in cancer
1个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
1个月前
已完结
MLKL activates the cGAS-STING pathway by releasing mitochondrial DNA upon necroptosis induction
7个月前
已完结
Design of a potent interleukin-21 mimic for cancer immunotherapy
7个月前
已完结
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
8个月前
已完结
皖公网安备34019202002308
